A citation-based method for searching scientific literature

Glenwood Goss, Chun-Ming Tsai, Frances A Shepherd, Lyudmila Bazhenova, Jong Seok Lee, Gee-Chen Chang, Lucio Crino, Miyako Satouchi, Quincy Chu, Toyoaki Hida, Ji-Youn Han, Oscar Juan, Frank Dunphy, Makoto Nishio, Jin-Hyoung Kang, Margarita Majem, Helen Mann, Mireille Cantarini, Serban Ghiorghiu, Tetsuya Mitsudomi. Lancet Oncol 2016
Times Cited: 368



Geoffrey R Oxnard, Kenneth S Thress, Ryan S Alden, Rachael Lawrance, Cloud P Paweletz, Mireille Cantarini, James Chih-Hsin Yang, J Carl Barrett, Pasi A Jänne. J Clin Oncol 2016
Times Cited: 530




List of shared articles



Times cited

Emerging Lab-on-a-Chip Approaches for Liquid Biopsy in Lung Cancer: Status in CTCs and ctDNA Research and Clinical Validation.
Ângela Carvalho, Gabriela Ferreira, Duarte Seixas, Catarina Guimarães-Teixeira, Rui Henrique, Fernando J Monteiro, Carmen Jerónimo. Cancers (Basel) 2021
0

Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring.
Damien Reita, Lucile Pabst, Erwan Pencreach, Eric Guérin, Laurent Dano, Valérie Rimelen, Anne-Claire Voegeli, Laurent Vallat, Céline Mascaux, Michèle Beau-Faller. Cancers (Basel) 2021
0

Efficacy of osimertinib for the treatment of previously EGFR TKI treated NSCLC patients: a meta-analysis.
Z-X Li, W Zhao, Q Sun, M-S Tang, Q-J Xia, M-S Dong. Clin Transl Oncol 2020
1

Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis.
Byoung Chul Cho, Dong-Wan Kim, Keunchil Park, Jong-Seok Lee, Seung Soo Yoo, Jin Hyoung Kang, Sung Yong Lee, Cheol Hyeon Kim, Seung Hun Jang, Young-Chul Kim,[...]. Curr Med Res Opin 2020
2

EGFR T790M relative mutation purity predicts osimertinib treatment efficacy in non-small cell lung cancer patients.
Qiufan Zheng, Shaodong Hong, Yan Huang, Hongyun Zhao, Yunpeng Yang, Xue Hou, Yuanyuan Zhao, Yuxiang Ma, Ting Zhou, Yaxiong Zhang,[...]. Clin Transl Med 2020
8